Intellia Therapeutics, Inc.

NTLA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$10.77+0.84%

2026-08-03

Financials

Valuation Metrics

Intellia Therapeutics, Inc.'s Market Cap is $1.50B. At end of 2025 it was $974M. Ranked #2232 of 3,111 in US market (top 72%), #888 of 1,445 on NASDAQ (top 61%), #164 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 61%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.50B	US#2,232/3,111 Sec#164/269
Revenue	$66M	US#2,846/3,111 Sec#147/269
Net Income	$-395M	US—/3,111 Sec—/269
Total Assets	$759M	US#2,569/3,111 Sec#115/269
Net Assets	$621M	US#2,105/3,111 Sec#92/269
Value
P/B	2.42x	US#1,433/3,111 Sec#68/269
P/S	22.77x	US#2,836/3,111 Sec#151/269
FCF Yield	-24.16%	US—/3,111 Sec—/269
Profitability
ROE	-63.55%	US#2,789/3,111 Sec#195/269
ROA	-52.00%	US#2,981/3,111 Sec#222/269
Op. Margin	-636.56%	US#2,912/3,111 Sec#169/269
Revenue Growth	-9.50%	US#2,663/3,111 Sec#147/269
Financial Health
Debt Ratio	22.20%	US#242/3,111 Sec#82/269
Total Debt	$80M	US#2,469/3,111 Sec#128/269
FCF	$-364M	US#2,814/3,111 Sec#248/269
Cash	$135M	US#2,020/3,111 Sec#154/269
Current Ratio	6.10x	US#391/3,111 Sec#129/269
Performance
1Y Return	-6.27%	US#2,269/3,111 Sec#209/269
1M Return	-38.67%	US#3,080/3,111 Sec#265/269
From 52W High	-61.88%	US#2,940/3,111 Sec#242/269
1Y MDD	-71.27%	US#2,939/3,111 Sec#246/269
Trading
Volume	2,960,856 shares	US#687/3,111 Sec#55/269
Trading Value	$32M	US#1,718/3,111 Sec#117/269
Per Share
EPS	$-3.81	US—/3,111 Sec—/269
BPS	$6.20	US#2,117/3,111 Sec#113/269